MADRIGAL PHARMACEUTICALS, INC. Property, Plant and Equipment, Gross
MADRIGAL PHARMACEUTICALS, INC. (MDGL) had Property, Plant and Equipment, Gross of $21.43 million as of 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Balance Sheet › Assets › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2016-05-10
- 2016-03-31: Property, Plant and Equipment, Gross $21.43M.
- 2015-12-31: Property, Plant and Equipment, Gross $21.57M.
- 2015-09-30: Property, Plant and Equipment, Gross $21.55M.
- 2015-06-30: Property, Plant and Equipment, Gross $21.53M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2016-03-31 | $21.43M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $21.57M 10-Q · filed 2016-05-10 |
| 2015-09-30 | $21.55M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $21.53M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $21.51M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $21.51M 10-K · filed 2016-03-15 |
| 2014-09-30 | $21.45M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $21.88M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $21.85M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $22.03M 10-K · filed 2015-03-12 |
| 2013-09-30 | $21.87M 10-Q · filed 2013-11-04 |
| 2013-06-30 | $21.94M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $21.55M 10-Q · filed 2013-04-30 |
| 2012-12-31 | $21.27M 10-K · filed 2014-03-11 |
| 2012-09-30 | $21.19M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $20.98M 10-Q · filed 2012-08-02 |
| 2011-12-31 | $20.77M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |